To investigate whether this hypothesis is translated in the clinical setting, we verified the presence and the expression of MTSS1, SCAMP1 and SERPIN B13 in a cohort of breast cancer patients by immunohistochemistry staining, using specific antibodies to these proteins. The gene discussed is SCAMP1; the disease is breast carcinoma.